Phosphoramidite Market Size to Reach USD 2.45 Billion by 2034, Driven by DNA Synthesis and Gene Therapy Research

The global phosphoramidite market size was valued at USD 1.29 billion in 2025 and is predicted to hit around USD 2.45 billion ...

Single enzyme streamlines production of all four RNA building blocks

A single enzyme that can generate all four nucleoside triphosphates, the building blocks of ribonucleic acid (RNA), has been ...
American Association of Individual Investors

Why Maravai LifeSciences Holdings, Inc.’s (MRVI) Stock Is Down 7.24%

As of Wednesday, January 28, Maravai LifeSciences Holdings, Inc.’s MRVI share price has dipped by 7.24%, which has investors ...
AZoLifeSciences on MSN

Single Enzyme Enables Low-Cost Synthesis of All RNA Nucleotides

A single enzyme that can generate all four nucleotide triphosphates, the building blocks of ribonucleic acid (RNA), was ...
Pharmabiz

Integrated DNA Technologies collaborates with Ansa Biotechnologies to expand capabilities to IDT’s synthetic biology portfolio

Integrated DNA Technologies collaborates with Ansa Biotechnologies to expand capabilities to IDT’s synthetic biology portfolio: Sunnyvale Saturday, January 17, 2026, 14:00 Hrs [ ...
TMCnet

Tsingke Biotech Launches New Website to Streamline Global Biotech R&D and Translational Services

BEIJING, Jan. 20, 2026 /PRNewswire/ -- Beijing Tsingke Biotech Co., Ltd., a leading biotechnology company, today announced ...

Integrated DNA Technologies Expands Synthetic Biology Portfolio with Ansa Biotechnologies' Clonal DNA and XL Clonal DNA Products

New collaboration empowers customers with sequence-perfect constructs as long as 50 kb Integrated DNA Technologies (IDT), a Danaher company and a global leader in genomics, and Ansa Biotechnologies, ...

Nanoparticle Contract Manufacturing Strategic Business Report 2025-2030: Which Application Areas and Client Segments Are Fueling Demand for Nanoparticle Manufacturing Services?

The Nanoparticle Contract Manufacturing market offers opportunities in pharmaceuticals, biotech, and advanced materials, driven by demand for complex nanoparticle formulations. CMOs enhance ...